Global Cellular Health Screening Market valued at USD 2.6 billion in 2022, is anticipated to witness a CAGR of 9% by 2027

Cellular health screening or testing is one of the key factors of health based on major factors such as human lifestyle, environment, emotions and diet. It can be used to examine the inflammatory diseases such as allergies, asthma, arthritis, autoimmune diseases, or inflammatory gastrointestinal issues. This test further helps in examining the patient’s progress throughout the medical treatment and offer detailed reports to monitor and assess further improvements on a cellular level. Cellular health screening helps in determining the cellular health & function, fat mass, intra & extracellular fluid levels, cellular toxicity, and muscle mass, etc.

Technological Developments and Innovations in the Global Cellular Health Screening Market

Constant developments and rapid innovations in the cellular health screening tests have enabled to develop an efficient but easy-to-use tests with better features such as automatic detection of telomers, fast turnaround time, and enhanced accuracy. Such developments and innovations tend to offer a competitive edge to all key manufacturers and vendors and hence, leading market players are focusing on new product development to boost their current position in the high growth market. 

Growing Research Activities to Trigger the Advancements and Developments in the Cellular Health Screening Market

Consistent growth in the global cellular health screening market is expected to be driven by the rising number of public awareness campaigns targeted at making people aware on the symptoms of chronic diseases and how to prevent them to further reduce various diseases and epidemics. Due to rising patient awareness and an increased demand, there is a decent demand for novel cellular health screening kits and services which has forced the researchers to emphasize on the market advancements and develop advanced diagnostic tests and kits.

Some of the recent advancement's are listed below-
  • In February 2023, Duke-NUS Medical School announced that Scientists at the Duke-NUS Medical School, National Heart Centre Singapore (NHCS) and colleagues in Singapore, China and the US have developed a test to quickly and precisely measure the length of a single telomere. The new approach is set to be used as a predictive biomarker for human ageing and disease at the individual level.

Competitive Landscape Analysis: Cellular Health Screening Market

The global cellular health screening market is marked by the presence of leading and established market players as listed below: -

  • Quest Diagnostics (US)
  • Telomere Diagnostics (US)
  • SpectraCell Laboratories (US)
  • Genova Diagnostics (US)
  • LabCorp Holdings (US)
  • Repeat Diagnostics, Inc. (Canada)
  • Life Length (Spain)

The global cellular health screening market is an emerging market and is poised to gain a consistent momentum in the coming years due to a major focus on healthcare advancements, global acceptance & growing awareness on preventive healthcare, rapidly growing aging population, and major focus of key market players to expand their global presence.

For instance, 

By 2030, 1 person in every 6 people in the world will be aged 60 years and above. Currently, the share of the population aged 60 years and above will rise from 1 billion in 2020 to reach 1.4 billion. Aging increases the greater risk of chronic diseases and infections which demands the preventive diagnostic tests, thus driving the global growth of the cellular health screening market.

Get Detailed Insights on Cellular Health Screening Market with a FREE Sample Report @ https://meditechinsights.com/cellular-health-screening-market/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Ambulatory Surgical Care is a medical care offered in the outpatient setting and does not need any hospital admission. Ambulatory Surgical Center or ASCs—are health care facilities focused on offering same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by offering a convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs are cataract surgery, gallbladder removal, tonsillectomy, endoscopy, colonoscopy, arthroscopic or orthopedic procedures, and cardiac procedures. Owing to their various cost benefits and convenience, the volume of procedures performed at ASCs is rising and ASC software is likely to play a major role in these settings by easing the day to day operations by preparing staff and patients for pre-op and post-op tasks. Rising Investments in Ambulatory Surgical Center  from Healthcare Companies Shows a Huge Growth Potential for Ambulatory Surgical Center Software Ma
Read more

Global Genomics Market Report Reveals Rapid Growth & Transformative Trends in the Genomic Industry by 2027

In the ever-evolving landscape of healthcare, genomics is making headlines for its groundbreaking contributions to personalized medicine, disease understanding, and advancements in pharmaceutical research. The Global Genomics Market Report for 2023 highlights the impressive growth and transformative trends within the genomics industry, shedding light on the exciting potential of genomics in shaping the future of healthcare. I. The Genomics Market Landscape The report's comprehensive analysis of the global genomics market reveals a dynamic and rapidly expanding landscape. With a CAGR of over [X]% during the forecast period, the industry is experiencing unprecedented growth. Key factors driving this growth include increased adoption of genomics in clinical diagnostics, expanding genomics research initiatives, and the development of advanced sequencing technologies. II. Personalized Medicine Revolution One of the most exciting trends highlighted in the report is the integration of ge
Read more